Phase II Study of Paclitaxel Given Once per Week Along With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.

Details

Language :

English

ISSN :

0732183X

Volume :

33

Issue :

5

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

100771153

Full Text :

https://doi.org/10.1200/JCO.2014.57.1745